NCT02798679View on ClinicalTrials.gov

Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

September 1, 2022

Study Completion Date

September 1, 2022

Conditions
Cardiotoxicity
Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT02798679 - Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity | Biotech Hunter | Biotech Hunter